FDA safety alert over radiofrequency ablation
This article was originally published in Clinica
MedWatch, the US FDA's reporting system for adverse events, has issued a warning over use of radiofrequency (RF) ablation devices. The warning follows reports of patient deaths associated with the use of RF during lung tumour ablation.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.